Observational studyPloS one2016

Comparative Effectiveness of Biosimilar, Reference Product and Other Erythropoiesis-Stimulating Agents (ESAs) Still Covered by Patent in Chronic Kidney Disease and Cancer Patients: An Italian Population-Based Study.

Ylenia Ingrasciotta et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.